Bioaffinity Technologies earnings were -$8.4M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest BIAF earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$2.0M, down 5.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, BIAF reported annual earnings of -$7.9M, with -2.7% growth.
Bioaffinity Technologies Earnings Reports & History FAQ
What were Bioaffinity Technologies's earnings last quarter?
Bioaffinity Technologies (NASDAQ: BIAF) reported Q3 2024 earnings per share (EPS) of -$0.16, up 38.46% year over year. Total BIAF earnings for the quarter were -$2.00 million. In the same quarter last year, Bioaffinity Technologies's earnings per share (EPS) was -$0.26.
Is Bioaffinity Technologies profitable or losing money?
As of the last Bioaffinity Technologies earnings report, Bioaffinity Technologies is currently losing money. Bioaffinity Technologies's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$8.45 million, a 16.68% increase year over year.
What was BIAF's earnings growth in the past year?
As of Bioaffinity Technologies's earnings date in Q1 2025, Bioaffinity Technologies's earnings has grown year over year. BIAF earnings in the past year totalled -$8.45 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.